A review proposes four phases for inflammation in ALS
Original source
Spatiotemporal Dynamics and Cellular States of Neuroinflammation in Amyotrophic Lateral Sclerosis: Implications for Stage‑Specific Therapeutics. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Study type
- Review
- Studied in
- Human, Animal
A review describes inflammation in amyotrophic lateral sclerosis (ALS) as changing over the course of disease. It proposes a four-phase framework that combines changes in immune cells in the brain and spinal cord with changes in peripheral immune responses. The framework is intended to guide research into treatments matched to disease stage.
Why this matters
The review may help researchers think about whether anti-inflammatory treatments should be studied differently at different stages of ALS. It is a conceptual framework, not evidence that stage-specific treatment improves outcomes, so it does not currently change treatment for people living with ALS.
Limitations and context
This is a review and proposed framework, not a new clinical trial. It draws on animal studies, human neuroimaging and post-mortem tissue, and the review says an integrated stage-dependent framework remains insufficiently established. The proposed phases and their treatment implications still need to be tested in clinical research.